Cargando…
Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study
INTRODUCTION: Major depressive disorder (MDD) is a disease with prominent individual, medical, and economic impacts. Drug therapy and other treatment methods (such as Electroconvulsive therapy) may induce treatment-resistance and have associated side effects including loss of memory, decrease of rea...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597483/ https://www.ncbi.nlm.nih.gov/pubmed/36312012 http://dx.doi.org/10.3389/fnins.2022.1018387 |
_version_ | 1784816101186600960 |
---|---|
author | Yi, Sijie Wang, Zhi Yang, Wenhan Huang, Chuxin Liu, Ping Chen, Yanjing Zhang, Huiting Zhao, Guangju Li, Weihui Fang, Jiliang Liu, Jun |
author_facet | Yi, Sijie Wang, Zhi Yang, Wenhan Huang, Chuxin Liu, Ping Chen, Yanjing Zhang, Huiting Zhao, Guangju Li, Weihui Fang, Jiliang Liu, Jun |
author_sort | Yi, Sijie |
collection | PubMed |
description | INTRODUCTION: Major depressive disorder (MDD) is a disease with prominent individual, medical, and economic impacts. Drug therapy and other treatment methods (such as Electroconvulsive therapy) may induce treatment-resistance and have associated side effects including loss of memory, decrease of reaction time, and residual symptoms. Transcutaneous auricular vagus nerve stimulation (taVNS) is a novel and non-invasive treatment approach which stimulates brain structures with no side-effects. However, it remains little understood whether and how the neural activation is modulated by taVNS in MDD patients. Herein, we used the regional homogeneity (ReHo) to investigate the brain activity in first-episode, drug-naïve MDD patients after taVNS treatment. MATERIALS AND METHODS: Twenty-two first-episode, drug-naïve MDD patients were enrolled in the study. These patients received the first taVNS treatment at the baseline time, and underwent resting-state MRI scanning twice, before and after taVNS. All the patients then received taVNS treatments for 4 weeks. The severity of depression was assessed by the 17-item Hamilton Depression Rating Scale (HAMD) at the baseline time and after 4-week’s treatment. Pearson analysis was used to assess the correlation between alterations of ReHo and changes of the HAMD scores. Two patients were excluded due to excessive head movement, two patients lack clinical data in the fourth week, thus, imaging analysis was performed in 20 patients, while correlation analysis between clinical and imaging data was performed in only 18 patients. RESULTS: There were significant differences in the ReHo values in first-episode, drug-naïve MDD patients between pre- or post- taVNS. The primary finding is that the patients exhibited a significantly lower ReHo in the left/right median cingulate cortex, the left precentral gyrus, the left postcentral gyrus, the right calcarine cortex, the left supplementary motor area, the left paracentral lobule, and the right lingual gyrus. Pearson analysis revealed a positive correlation between changes of ReHo in the right median cingulate cortex/the left supplementary motor area and changes of HAMD scores after taVNS. CONCLUSION: The decreased ReHo were found after taVNS. The sensorimotor, limbic and visual-related brain regions may play an important role in understanding the underlying neural mechanisms and be the target brain regions in the further therapy. |
format | Online Article Text |
id | pubmed-9597483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95974832022-10-27 Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study Yi, Sijie Wang, Zhi Yang, Wenhan Huang, Chuxin Liu, Ping Chen, Yanjing Zhang, Huiting Zhao, Guangju Li, Weihui Fang, Jiliang Liu, Jun Front Neurosci Neuroscience INTRODUCTION: Major depressive disorder (MDD) is a disease with prominent individual, medical, and economic impacts. Drug therapy and other treatment methods (such as Electroconvulsive therapy) may induce treatment-resistance and have associated side effects including loss of memory, decrease of reaction time, and residual symptoms. Transcutaneous auricular vagus nerve stimulation (taVNS) is a novel and non-invasive treatment approach which stimulates brain structures with no side-effects. However, it remains little understood whether and how the neural activation is modulated by taVNS in MDD patients. Herein, we used the regional homogeneity (ReHo) to investigate the brain activity in first-episode, drug-naïve MDD patients after taVNS treatment. MATERIALS AND METHODS: Twenty-two first-episode, drug-naïve MDD patients were enrolled in the study. These patients received the first taVNS treatment at the baseline time, and underwent resting-state MRI scanning twice, before and after taVNS. All the patients then received taVNS treatments for 4 weeks. The severity of depression was assessed by the 17-item Hamilton Depression Rating Scale (HAMD) at the baseline time and after 4-week’s treatment. Pearson analysis was used to assess the correlation between alterations of ReHo and changes of the HAMD scores. Two patients were excluded due to excessive head movement, two patients lack clinical data in the fourth week, thus, imaging analysis was performed in 20 patients, while correlation analysis between clinical and imaging data was performed in only 18 patients. RESULTS: There were significant differences in the ReHo values in first-episode, drug-naïve MDD patients between pre- or post- taVNS. The primary finding is that the patients exhibited a significantly lower ReHo in the left/right median cingulate cortex, the left precentral gyrus, the left postcentral gyrus, the right calcarine cortex, the left supplementary motor area, the left paracentral lobule, and the right lingual gyrus. Pearson analysis revealed a positive correlation between changes of ReHo in the right median cingulate cortex/the left supplementary motor area and changes of HAMD scores after taVNS. CONCLUSION: The decreased ReHo were found after taVNS. The sensorimotor, limbic and visual-related brain regions may play an important role in understanding the underlying neural mechanisms and be the target brain regions in the further therapy. Frontiers Media S.A. 2022-10-12 /pmc/articles/PMC9597483/ /pubmed/36312012 http://dx.doi.org/10.3389/fnins.2022.1018387 Text en Copyright © 2022 Yi, Wang, Yang, Huang, Liu, Chen, Zhang, Zhao, Li, Fang and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Yi, Sijie Wang, Zhi Yang, Wenhan Huang, Chuxin Liu, Ping Chen, Yanjing Zhang, Huiting Zhao, Guangju Li, Weihui Fang, Jiliang Liu, Jun Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study |
title | Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study |
title_full | Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study |
title_fullStr | Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study |
title_full_unstemmed | Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study |
title_short | Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study |
title_sort | neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: a resting-state fmri study |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597483/ https://www.ncbi.nlm.nih.gov/pubmed/36312012 http://dx.doi.org/10.3389/fnins.2022.1018387 |
work_keys_str_mv | AT yisijie neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT wangzhi neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT yangwenhan neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT huangchuxin neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT liuping neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT chenyanjing neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT zhanghuiting neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT zhaoguangju neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT liweihui neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT fangjiliang neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy AT liujun neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy |